Description: |
Benserazide is a peripherally-acting aromatic L-amino acid decarboxylase (AAAD) or DOPA decarboxylase inhibitor. It inhibits this decarboxylation, and since it itself cannot cross the blood-brain barrier, this allows dopamine to build up solely in the brain instead. Adverse effects caused by peripheral dopamine, such as nausea and arrhythmia, are minimized. However, benserazide cannot reduce the centrally-mediated side effects of levodopa, particularly dyskinesia.For the detailed information of Benserazide, the solubility of Benserazide in water, the solubility of Benserazide in DMSO, the solubility of Benserazide in PBS buffer, the animal experiment (test) of Benserazide, the cell expriment (test) of Benserazide, the in vivo, in vitro and clinical trial test of Benserazide, the EC50, IC50,and Affinity of Benserazide, Please contact DC Chemicals. |